Post Cardiac Surgery Hemodynamics Diagnostic Device
Post Cardiac Surgery Hemodynamics Diagnostic Device
批准号:
10707900
负责人:
Anil Kottam
金额:
$95.89万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-30 至 2024-07-31
关键词:
Acute Kidney FailureAgeAged, 80 and overAmericanAnimalsBlood VolumeBypassCardiacCardiac Surgery proceduresCardiac VolumeCardiovascular systemCaregiversCathetersChestClinicalClinical ResearchClinical TrialsConfusionConnective TissueCoronaryDangerousnessDetectionDevelopmentDevicesDiagnosisDiagnosticDiagnostic EquipmentDialysis procedureDifferential DiagnosisDiscriminationDoctor of PhilosophyDrainage procedureElectrodesElectronicsEngineeringEnsureEpicardiumEvaluation StudiesFamily suidaeHealthHeartHeart failureHospitalsHumanHypotensionHypotensivesHypovolemiaHypovolemicsImplantIncidenceInfectionIntensive Care UnitsKidneyKnowledgeLiquid substanceLow Cardiac OutputMarketingMeasurementMeasuresMedicalModificationMonitorMorbidity - disease rateMorphologyMyocardiumOctogenarianOperative Surgical ProceduresOutcomePatientsPerformancePericardial body locationPhasePopulationPostoperative PeriodPrincipal InvestigatorProceduresPulmonary artery structureQualifyingRecoveryResearchResearch PersonnelResourcesRiskSafetySmall Business Innovation Research GrantSpecialistSpecific qualifier valueSternotomySurfaceSystemSystems DevelopmentTestingTimeTubeUnited States National Institutes of HealthVascular blood supplyWorkage relatedaging populationclinical efficacyclinically actionabledesignempowermentflexibilityheart damagehemodynamicshigh riskhospital readmissionhuman old age (65+)implantationimprovedinventionmanufacturabilitymortalitynew technologynovelolder patientpericardial sacpre-clinicalpreclinical studypressurepreventprophylacticprototyperesponsetouchscreenvalve replacementverification and validation
中文摘要
摘要
冠状动脉旁路移植术(CABG)和瓣膜置换术是一种心脏直视手术,
每年在40万美国人身上进行。心脏手术患者的平均年龄是
60岁出头,其中52%的人65岁以上,8%的人80岁以上。八十多岁的人
越来越多的人被转介接受心脏手术,因为老龄化人口正在增加
迅速,他们仍然从冠脉搭桥术中受益足够多,以提高长期生存率,尽管
风险。然而,他们也有更长的术后在ICU和医院的停留时间,以及更高的死亡率
再次住进重症监护室。这一人群中不明原因的低血压尤其令人担忧
复苏,因为尽管压力经常被连续测量,但歧视
在适当的疗程之间,需要额外测量心脏体积。这个
以前的容量管理标准(部分植入的肺动脉导管,或
PAC)现在被认为对预防性植入来说风险太大,因为另一种
侵入性手术,感染,缺乏改变结果的证据。没有关于的信息
容量状况,多天恢复,只有最少的床边医院工作人员在场,使
不明原因低血压的正确诊断和快速治疗是棘手的。在较老的心脏中
手术患者,与年龄相关的心脏形态改变导致收缩功能下降
储备减少,依从性降低,变力反应迟钝。这会导致低血压
对心脏损伤或虚弱的正确诊断可能与低血压混淆的情况
容量状态(低血容量)和需要探查手术的血管顺应性降低。全
在这种情况下,不确定的工作人员会谨慎地要求Echo、常驻研究员或其他有空人员
心血管专家推断患者的低血压状态时的容量
持续存在,增加了风险。BSM建议修改无处不在的心包引流管,以
在没有PAC的情况下区分这两种状态,使用一种新的、经临床验证的
体量测量,使工作人员能够迅速采取适当的临床行动方案
稳定老年患者。
英文摘要
Abstract
Coronary arterial bypass graft (CABG) and valve replacements are open-heart surgeries that
are performed on 400,000 Americans each year. The average age of cardiac surgery patients is
early 60s, with 52% over the age of 65, and 8% over the age of 80. Octogenarians are
increasingly being referred for cardiac surgery, because the aging population is increasing
rapidly, and they still benefit enough from CABG to improve long term survival despite higher
risk. However, they also have longer post-operative stays in ICU and hospital, and higher rates
of ICU readmission. Unexplained hypotension in this population is of particular concern during
recovery, because although pressures are routinely measured continuously, discrimination
between proper treatment courses requires an additional measure of heart volumes. The
previous standard for volume management (a partially implanted Pulmonary Artery Catheter, or
PAC) is now considered too risky for prophylactic implantation due to the added risks of another
invasive procedure, infection, lack of evidence that it changes outcomes. Without information on
volume status, multiple day recovery with only minimal bedside hospital staff present makes the
proper diagnosis and rapid treatment of unexplained hypotension tricky. In the older cardiac
surgery patient, age-related modifications in cardiac morphology result in decreased contractile
reserve, reduced compliance, and blunted inotropic response. This leads to hypotensive
situations where the proper diagnosis of cardiac damage or weakness can be confused with low
volume status (hypovolemia) and reduced vessel compliance requiring exploratory surgery. All
unsure staff in this situation prudently call for an echo, the resident fellow, or other available
cardiovascular specialists to infer what the volume is while the patient’s hypotensive state
persists, increasing risk. BSM proposes to modify the ubiquitously placed pericardial drain to
discriminate among these two states without a PAC, by using a novel, clinically-validated
volume measurement, empowering staff to take the proper clinical course of action quickly to
stabilize elderly patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Post Cardiac Surgery Hemodynamics Diagnostic Device
-
批准号:10453483
-
项目类别:
-
资助金额:$74.03万
-
财政年份:2022
-
负责人:Anil Kottam
-
依托单位:
Post Cardiac Surgery Hemodynamics Diagnostic Device
-
批准号:10256581
-
项目类别:
-
资助金额:$25.65万
-
财政年份:2021
-
负责人:Anil Kottam
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: